Steward Partners Investment Advisory LLC Sells 254 Shares of The Clorox Company (NYSE:CLX)

Steward Partners Investment Advisory LLC trimmed its holdings in The Clorox Company (NYSE:CLX) by 2.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,614 shares of the company’s stock after selling 254 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Clorox were worth $1,399,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. SBI Securities Co. Ltd. purchased a new position in Clorox in the 4th quarter worth approximately $78,000. Jones Financial Companies Lllp raised its position in shares of Clorox by 35.5% during the fourth quarter. Jones Financial Companies Lllp now owns 9,543 shares of the company’s stock valued at $1,550,000 after buying an additional 2,500 shares during the last quarter. Modera Wealth Management LLC lifted its holdings in shares of Clorox by 7.0% in the fourth quarter. Modera Wealth Management LLC now owns 4,953 shares of the company’s stock worth $804,000 after buying an additional 322 shares in the last quarter. Halbert Hargrove Global Advisors LLC bought a new position in shares of Clorox during the fourth quarter worth $36,000. Finally, Smartleaf Asset Management LLC grew its stake in Clorox by 33.1% during the fourth quarter. Smartleaf Asset Management LLC now owns 965 shares of the company’s stock valued at $156,000 after acquiring an additional 240 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.8 %

NYSE CLX opened at $151.11 on Monday. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The firm has a market capitalization of $18.61 billion, a price-to-earnings ratio of 41.29, a PEG ratio of 2.62 and a beta of 0.45. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The company has a fifty day moving average of $155.65 and a two-hundred day moving average of $160.47.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the firm posted $2.16 earnings per share. On average, analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.23%. Clorox’s payout ratio is 133.33%.

Wall Street Analyst Weigh In

Several brokerages have commented on CLX. DA Davidson decreased their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Barclays boosted their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Wells Fargo & Company raised their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. JPMorgan Chase & Co. upped their price objective on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and an average price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.